Smartphone Use Restriction as Treatment of Primary Headache
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to study smartphone use restriction as a treatment modality in patients of primary headache. The main question\[s\] it aims to answer are:
- 1.In patients with primary headache, does restriction of smartphone use lead to reduced consumption of medications (acute, prophylaxis, either or both)?
- 2.In patients with primary headache, does restriction of smartphone use lead to better responsiveness to medications (acute, prophylaxis, either or both)?
- 3.Can reduction of smartphone duration be used as a non-pharmacological treatment of primary headache?
- 4.In patients with primary headache, is the type of smartphone use (phone calls, internet browsing, watching screen) determinant of the severity of headache?
- 5.Can we make an addiction score to predict which patient should be advised to limit smartphone use based on the above information?
- 6.In patients with primary headache, does restriction of smartphone use led to improvement in headache severity (frequency, intensity, duration, one of them or all).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 18, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
December 2, 2024
November 1, 2024
3 years
September 12, 2023
November 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The pill burden for abortive treatment
The number of times the patient is using acute pain medications for headache in one month
three months after initiation of study period
Secondary Outcomes (2)
Headache frequency
One and three months
Number of prophylactic medication
Three months
Study Arms (2)
Smartphone restriction
EXPERIMENTALPatients with headache with history of high smartphone use will be randomized into restriction and no-restriction arm. Restriction method: In the 'run-in' period of four weeks, the smartphone usage will be assessed in terms of number of overall use. The patients will then be advised to cut down the usage by one-third in terms of usage hours. The compliance will be checked at the time of outcome assessment.
Control
NO INTERVENTIONComparison: In the 'run-in' period of four weeks, the smartphone usage will be assessed in terms of number of overall use. In the non-intervention group only the smartphone usage data will be collected in the study period. The non-smartphone users will be as another control arm.
Interventions
The patients will then be advised to cut down the usage by one-third in terms of usage hours. The compliance will be checked at the time of outcome assessment.
Eligibility Criteria
You may qualify if:
- Patients ≥18 years of age
- Diagnosis of primary headache as per the ICHD3Beta classification ("ICHD-3 The International Classification of Headache Disorders 3rd Edition" n.d.)
- Willing and consenting to participate in the study.
You may not qualify if:
- \. Secondary headaches 2. Not consenting for participation or follow up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Deepti Vibha
New Delhi, National Capital Territory of Delhi, 110029, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deepti Vibha
All India Institute of Medical Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 18, 2023
Study Start
October 1, 2023
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
December 2, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After the completion of the publication for six months
- Access Criteria
- Shared on individual request
Anonymized data will be shared on reasonable request